CVE-2026-21980 | Teknoloji dünyasından en güncel haberleri ve güvenlikle ilgili gelişmeleri takip edin.

Vulnerability in the Oracle Life Sciences Central Coding product of Oracle Health Sciences Applications (component: Platform). The supported version that is a…
Medium CVSS: 6.5

CVE-2026-21980

Vulnerability in the Oracle Life Sciences Central Coding product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Coding. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences Central Coding accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Central Coding accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N).
Vendor
Oracle
Product
Life Sciences Central Coding
CWE
NVD-CWE-noinfo
Yayın Tarihi
2026-01-20 22:16:01
Güncelleme
2026-01-29 14:46:09
Source Identifier
secalert_us@oracle.com
KEV Date Added
-

Kategoriler

Referanslar